Interleukin-6 triggers human cerebral smooth muscle cell proliferation

Jinghua S Yao,Zheng Xue,William L Young,Guo-Yuan Yang
DOI: https://doi.org/10.1038/sj.jcbfm.9591524.0112
2005-01-01
Abstract:Interleukin-6 (IL-6), a pleriotropic cytokine, is proposed to play a crucial role in inflammatory response (ref). Further study shows that IL-6 also plays important roles during angiogenesis and vascular remodelling, depending upon cell types. We investigated the effects of IL-6 on a major cell type crucial for remodelling, human cerebral vascular smooth muscle cells (HCSMCs). HCSMCs were grown to confluence on gelatin coated 35 mm dishes and then treated with IL-6 protein at different concentrations (25–200 ng/ml). HCSMC proliferation was determined using a BrdU assay kit, and migration was determined using a HCSMC invasion assay. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor, the kinase insert domain–containing receptor (KDR), and matrix metalloproteinase (MMP)-3, -9 protein and mRNA levels were determined using Western blot analysis, ELISA, and real time –polymerase chain reaction (RT-PCR) assay, respectively. MMP-9 activity was determined using MMP zymography. VEGF had a minimal mitogenic effect on HCSMCs. However, IL-6 induced HCSMC proliferation and migration in a dose dependent manner. To explore the signal transduction pathway for the effect of IL-6 on HCSMC proliferation, we studied the downstream factor expression in HCSMCs (VEGF, MMP-3, -9). IL-6 significantly enhanced VEGF, MMP-3, -9 both mRNA and protein expression levels in HCSMCs compared with the control (without IL-6 treatment, p<0.05), respectively. Neutralizing or inhibiting IL-6 and/or VEGF using antibodies or inhibitors could block IL-6 induced HCSMC proliferation. Importantly, we demonstrated that IL-6 directly activated KDR phosphorylation in the IL-6 treated HCSMCs. Blocking KDR abolished IL-6 induced HCSMC proliferation. Our results indicate that the IL-6 treatment accelerated HCSMC proliferation through stimulation of the VEGF-KDR-MMP signal pathway. We provide the first evidence that IL-6, by triggering KDR phosphorylation, plays an important role in IL-6 induced HCSMC proliferation. HCSMC-derived MMPs could be an additional source of proteases to digest vascular basement membranes, potentially providing a key step in the initial stage of brain angiogenesis. MMPs may also contribute to HCSMC migration in angiogenesis. Supported by NIH grants: PO1 NS and RO1 NS27713 (WLY) and R21 NS45123 (GYY)
What problem does this paper attempt to address?